Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Cytek Biosciences Inc CTKB

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion... see more

Recent & Breaking News (NDAQ:CTKB)

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

GlobeNewswire May 20, 2024

Cytek Biosciences Reports First Quarter 2024 Financial Results

GlobeNewswire May 8, 2024

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

GlobeNewswire April 30, 2024

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

GlobeNewswire April 29, 2024

Cytek® Biosciences Names William McCombe Chief Financial Officer

GlobeNewswire March 19, 2024

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

GlobeNewswire March 7, 2024

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

GlobeNewswire February 28, 2024

Cytek Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire February 7, 2024

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

GlobeNewswire February 7, 2024

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries

GlobeNewswire January 17, 2024

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

GlobeNewswire January 8, 2024

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 28, 2023

Cytek® Biosciences Introduces the Cytek Orion(TM) Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

GlobeNewswire December 21, 2023

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire November 14, 2023

Cytek® Aurora(TM) CS System Wins BioTech Breakthrough Award for 'Cell Sorting Product of the Year'

GlobeNewswire November 8, 2023

Cytek Biosciences Reports Third Quarter 2023 Financial Results

GlobeNewswire November 7, 2023

Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023

GlobeNewswire October 19, 2023

Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters

GlobeNewswire September 27, 2023

Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 20, 2023

Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe

GlobeNewswire September 20, 2023